Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<ul><li>BullFrog has delivered key milestones in its first big pharma program.</li><li>On October 6, the company announced it had achieved key project milestones under its commercial engagement with a top five global pharmaceutical company, identifying and prioritizing multiple novel targets for major depressive disorder (MDD) using proprietary neuropsychiatric multi-omic data.</li><li>CEO Vin Singh called the project “crucial commercial scale validation” of the technology. </li></ul>

BullFrog has delivered key milestones in its first big pharma program.On October 6, the company announced it had achieved key project milestones under its commercial engagement with a top five global pharmaceutical company, identifying and prioritizing multiple novel targets for major depressive disorder (MDD) using proprietary neuropsychiatric multi-omic data.CEO Vin Singh called the project “crucial commercial scale validation” of the technology. 

BFRG: Milestones Hit; Expansion Could Be the Next Big Hop

<ul><li>Singh’s goal is an expansion with the large pharma customer in 4Q on standard commercial terms rather than pilot terms.</li><li>The engagement, announced at the end of March, is a six- to 12-month pilot in which the customer will select one major depressive disorder target to advance in-house.</li><li>Bullfrog has delivered a couple of interim milestones and booked its first revenue in 2Q. </li></ul>

Singh’s goal is an expansion with the large pharma customer in 4Q on standard commercial terms rather than pilot terms.The engagement, announced at the end of March, is a six- to 12-month pilot in which the customer will select one major depressive disorder target to advance in-house.Bullfrog has delivered a couple of interim milestones and booked its first revenue in 2Q. 

BFRG: Land, Prove, Expand - Pharma Moves Toward Conversion

<ul><li>First Hop – The Big Pharma Pilot Starts Paying. BullFrog recorded its first collaboration revenue after completing the first deliverable under its top five pharma agreement.</li><li>The filed accounting recognizes each deliverable at a point in time when completed. </li><li>2Q revenue of $215K was above our expectation for no revenue; we were modeling first revenue in 4Q26. </li></ul>

First Hop – The Big Pharma Pilot Starts Paying. BullFrog recorded its first collaboration revenue after completing the first deliverable under its top five pharma agreement.The filed accounting recognizes each deliverable at a point in time when completed. 2Q revenue of $215K was above our expectation for no revenue; we were modeling first revenue in 4Q26. 

BFRG: 2Q26 Results; First Hop - The Big Pharma Pilot Starts Paying

<ul><li>BullFrog AI Holdings, Inc. (NASDAQ: BFRG) uses artificial intelligence (AI) to increase the success rate of drug development while reducing the time and investment it requires. </li><li>Based in Gaithersburg, MD and public since February 2023, the company was founded in 2017 by Vin Singh, who earlier co-founded the life sciences firm MaxCyte, Inc. (NASDAQ: MXCT). </li><li>BullFrog addresses a significant challenge in drug development: bringing a new drug to market typically requires 10-15 years and $1-2 billion in investment, yet many late-stage programs still fail.</li></ul>

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) uses artificial intelligence (AI) to increase the success rate of drug development while reducing the time and investment it requires. Based in Gaithersburg, MD and public since February 2023, the company was founded in 2017 by Vin Singh, who earlier co-founded the life sciences firm MaxCyte, Inc. (NASDAQ: MXCT). BullFrog addresses a significant challenge in drug development: bringing a new drug to market typically requires 10-15 years and $1-2 billion in investment, yet many late-stage programs still fail.

BFRG: Initiating Coverage; Helping Big Pharma Look Before It Leaps in Drug Discovery

Thematic (Sector/Industry)

<div><ul><li>The WTR AI Flow Newsletter highlights recent developments in AI and quantum. </li><li>We curate the top 10 AI and Quantum stories in the past month and classify them as “Rising” or “Falling,” and provide takeaways.</li><li>A foot on the AI accelerator and the brake. The period pulled in both directions. </li></ul></div>

The WTR AI Flow Newsletter highlights recent developments in AI and quantum. We curate the top 10 AI and Quantum stories in the past month and classify them as “Rising” or “Falling,” and provide takeaways.A foot on the AI accelerator and the brake. The period pulled in both directions. 

AI Flow Newsletter : Monitoring The "Currents" Of AI - 4 August 2026

United States

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company. The Company focuses on AI technology development which enables precise identification of meaningful data for more agile drug development. Bullfrog AI Holdings serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bullfrog AI Holdings (BFRG US)

BFRG: Milestones Hit; Expansion Could Be the Next Big Hop

BullFrog has delivered key milestones in its first big pharma program. On October 6, the company announced it had achieved key project milestones...

Water Tower Research

BFRG: Land, Prove, Expand - Pharma Moves Toward Conversion

The engagement, announced at the end of March, is a six- to 12-month pilot in which the customer will select one major depressive disorder target...

Water Tower Research

BFRG: 2Q26 Results; First Hop - The Big Pharma Pilot Starts Paying

First Hop – The Big Pharma Pilot Starts Paying. BullFrog recorded its first collaboration revenue after completing the first deliverable under...

Water Tower Research

BFRG: Initiating Coverage; Helping Big Pharma Look Before It Leaps in Drug Discovery

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) uses artificial intelligence (AI) to increase the success rate of drug development while reducing the...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

BFRG: Milestones Hit; Expansion Could Be the Next Big Hop

BullFrog has delivered key milestones in its first big pharma program. On October 6, the company announced it had achieved key project milestones...

Water Tower Research

BFRG: Land, Prove, Expand - Pharma Moves Toward Conversion

The engagement, announced at the end of March, is a six- to 12-month pilot in which the customer will select one major depressive disorder target...

Water Tower Research

BFRG: 2Q26 Results; First Hop - The Big Pharma Pilot Starts Paying

First Hop – The Big Pharma Pilot Starts Paying. BullFrog recorded its first collaboration revenue after completing the first deliverable under...

Water Tower Research

BFRG: Initiating Coverage; Helping Big Pharma Look Before It Leaps in Drug Discovery

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) uses artificial intelligence (AI) to increase the success rate of drug development while reducing the...

Water Tower Research

AI Flow Newsletter : Monitoring The "Currents" Of AI - 4 August 2026

We curate the top 10 AI and Quantum stories in the past month and classify them as “Rising” or “Falling,” and provide takeaways.A foot on the AI...

Water Tower Research